Breaking Down the Barriers of Drug Resistance and Corneal Permeability with Chitosan-Poly(ethylene glycol)-LK13 Peptide Conjugate to Combat Fungal Keratitis
- 11 July 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 10 (8) , 2950-2960
Abstract
Fungal keratitis (FK) is a leading cause of preventable blindness and eye loss. The poor antifungal activity, increased drug resistance, limited corneal permeability, and unsatisfactory biosafety of conventional antifungal eye drops are among the majority of the challenges that need to be addressed for currently available antifungal drugs. Herein, this study proposes an effective strategy that employs chitosan-poly(ethylene glycol)-LK13 peptide conjugate (CPL) in the treatment of FK. Nanoassembly CPL can permeate the lipophilic corneal epithelium in the transcellular route, and its hydrophilicity surface is a feature to drive its permeability through hydrophilic stroma. When encountering fungal cell membrane, CPL dissembles and exposes the antimicrobial peptide (LK13) to destroy fungal cell membranes, the minimum inhibitory concentration values of CPL against Fusarium solani (F. solani) are always not to exceed 8 μg peptide/mL before and after drug resistance induction. In a rat model of Fusarium keratitis, CPL demonstrates superior therapeutic efficacy than commercially available natamycin ophthalmic suspension. This study provides more theoretical and experimental supports for the application of CPL in the treatment of FK.Keywords
Funding Information
- Natural Science Foundation of Tianjin Municipality (TJLCZDXKM002)
- Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences
- National Natural Science Foundation of China (31971303, 52073293, 82204326)
- Tianjin Key Medical Discipline Construction Project (TJYXZDXK-037A)
This publication has 38 references indexed in Scilit:
- Microbiological Characteristics and Risk Factors Involved in Progression from Fungal Keratitis with Hypopyon to Keratitis-Related EndophthalmitisMycopathologia, 2023
- Natamycin Ocular Delivery: Challenges and Advancements in Ocular TherapeuticsAdvances in Therapy, 2023
- Antimicrobial peptides for combating drug-resistant bacterial infectionsDrug Resistance Updates, 2023
- Overcoming the Stromal Barrier of the Cornea with a Peptide Conjugate Nano‐Assembly to Combat Fungal KeratitisAdvanced Healthcare Materials, 2023
- Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South IndiaJAMA Ophthalmology, 2022
- From Antimicrobial Peptides to Antimicrobial Poly(α‐amino acid)sAdvanced Healthcare Materials, 2018
- Advances in the transepithelial transport of nanoparticlesDrug Discovery Today, 2016
- Update on Antifungal Drug ResistanceCurrent Clinical Microbiology Reports, 2015
- Multistate Outbreak of Fusarium Keratitis Associated With Use of a Contact Lens SolutionJAMA, 2006
- Pharmacologic management of keratomycosesSurvey of Ophthalmology, 1988